WOSU: Ohio fails to pick president for first time since 1960
Political scientist David Niven says Ohio no longer mirrors the overall national vote.
Since 1960 Ohio had been a bellwether for predicting presidential election outcomes, but that’s no longer the case, UC political scientist David Niven tells WOSU radio in a post-election interview.
In the 2020 election Ohio went for Trump, but Biden is the projected winner.
“Not only shouldn’t we have been a toss-up, we weren’t anywhere close to being one," Niven says. "And the future battle for the presidencies is highly unlikely to run through Ohio."
Along with Trump's wins in 2016 and 2020, Ohio has seen Republicans sweep its statewide executive races – governor, attorney general, secretary of state, treasurer and auditor – twice since 2010.
Listen to the entire interview on WOSU.
Featured image at top of voting sticker. Photo/Phillip Goldsberry/Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.